Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - trimethoprim; sulfadimidine - oral powder, pre-mix - trimethoprim pyrimidine active 86.0 mg/g; sulfadimidine sulfanyl active 430.0 mg/g - antibiotic & related - calf | horse | pigs | poultry | beef calf | boar | bovine | breeders | broiler | calf - poddy | calf - preweaning | calf - sucke - bacterial infection | brucella spp. | corynebacterium - exclusions see label | enterobacter spp. | escherichia coli (e. coli) | fusobacterium spp. | haemophilus spp. | klebsiella spp. | nocardia spp. | organisms sensitive to combination of | pasteurella spp. | proteus spp. | pseudomonas spp. | salmonella | shigella spp. | staphylococci | streptococci | amoxycillin sensitive bacteria | anaerobic bacteria | associated with viral disease | bacterial canker | brucella abortus | brucella melitensis | brucella suis | gram negative organisms | gram positive organisms | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | pasterellosis | pasteurellosis | post parturient bacterial infe | primary bacterial infection | salmonellosis | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 60.0 m cfu/g; enterococcus faecium biological-organism active 60.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 60.0 m cfu/g; lactobacillus acidophilus biological-organism active 60.0 m cfu/g; lactobacillus plantarum biological-organism active 60.0 m cfu/g; lactobacillus rhamnosus biological-organism active 60.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 60.0 m cfu/g - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rufus & coco pty. ltd. - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 180.0 m cfu/g; enterococcus faecium biological-organism active 180.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 180.0 m cfu/g; lactobacillus acidophilus biological-organism active 180.0 m cfu/g; lactobacillus plantarum biological-organism active 180.0 m cfu/g; lactobacillus rhamnosus biological-organism active 180.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 180.0 m cfu/g - nutrition & metabolism - animal | birds | dog - puppy | kitten | aviary bird | breeders | broilers | budgerigars | canaries | chickens | chooks | domesti - diarrhoea | intestinal dysfunction | re-establishment of gut microflora | stress | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | following antibiotic use | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | post-antibiotic therapy | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Malta - English - Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - haemophilus influenzae, b, tetanus toxoid - powder and solvent for solution for infusion - haemophilus influenzae b 10 µg tetanus toxoid 25 µg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - haemophilus influenzae type b polysaccharide; conjugate of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid - powder and solvent for solution for injection - 0.5 millilitre(s) - hemophilus influenzae b, combinations with toxoids

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - haemophilus type b polysaccharide, quantity: 10 microgram; tetanus protein, quantity: 18 microgram - injection, powder for - excipient ingredients: trometamol; sucrose - for use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the haemophilus influenzae type b.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - tetanus toxoid, quantity: 40 microgram/ml; haemophilus influenza type b polyribose ribitol phosphate, quantity: 20 microgram/ml - injection, powder for - excipient ingredients: water for injections; sodium chloride; lactose - hiberix is indicated for active immunisation against haemophilus influenzae type b infection in children aged from 2 months to 5 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - haemophilus type b polysaccharide, quantity: 10 microgram; tetanus protein, quantity: 18 microgram - injection, powder for - excipient ingredients: trometamol; sucrose - for use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the haemophilus influenzae type b.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - amoxicillin trihydrate - powder - 3gram

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advanced probiotics international, llc - bifidobacterium longum; bifidobacterium thermophilum; bacillus subtilis; lactobacillus acidophilus; saccharomyces cerevisiae; streptococcus faecium; alpha amylase (from b. subtilis); beta glucanase; hemicellulase (b. subtilus) - oral powder, pre-mix - bifidobacterium longum biological-organism active 0.0 cfu/g; bifidobacterium thermophilum biological-organism active 0.0 cfu/g; bacillus subtilis biological-organism active 0.0 cfu/g; lactobacillus acidophilus biological-organism active 0.0 cfu/g; saccharomyces cerevisiae biological-organism active 0.0 cfu/g; streptococcus faecium vaccine-microbial active 0.0 cfu/g; alpha amylase (from b. subtilis) enzyme other 132000.0 bau/kg; beta glucanase enzyme other 9000.0 bgu/kg; hemicellulase (b. subtilus) enzyme other 8800.0 hcu/kg - nutrition & metabolism - calf | cattle | dairy cattle | beef | beef calf | bos indicus | bos taurus | bovine | breeders | buffalo | bull | bullock | calf - feed additive